Health charity Scleroderma & Raynaud's UK (SRUK) is urging the public to take a 60-second online test to find out if they may ...

Fecal microbiota transplantation with an anaerobic cultivated human intestinal microbiome failed to improve gastrointestinal symptoms in patients with systemic sclerosis, a phase 2 study showed.

The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.

The company is evaluating whether the drug, which targets cardiac complications, might be used treat patients with other ...

Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

Researchers at Linköping University in Sweden made an unexpected discovery while investigating genetically unique women.

Biogen posted strong Q4 results, surpassing estimates, while forecasting a 2025 revenue decline. The company secured up to ...

Rheumatic and vascular diseases currently affect a large part of the population and can significantly compromise the biomechanics of the lower limb. This condition will be discussed on Saturday, ...

In a challenging economic climate, ZURA's stock has hit a 52-week low, dropping to $1.44, marking a steep 11.7% decline in just the past week. According to InvestingPro analysis, the company appears ...